Scholarlink

Background <p>Acute pancreatitis (AP) is one of the serious complications among patients with hematopoietic stem cell transplantation (HSCT). We aimed to evaluate the impact of AP on hospitalization outcomes in pediatric HSCT recipients.</p> Methods <p>We retrospectively queried the PHIS database to include all pediatric patients who underwent HSCT between 2005-2024. The study population was divided into those with and without AP, and compared for various demographic and clinical variables. The primary outcome was in-hospital mortality, and secondary outcomes included healthcare resource utilization.</p> Results <p>A total of 33,439 HSCT recipients were identified, and the prevalence rate of AP was 1.1%. The AP group had a significantly higher in-hospital mortality rate (22.7% vs. 4.6%), higher median hospitalization costs (USD 698,372 vs. 187,583), and higher median length of stay (138.5 vs. 60 days) (all p &lt; 0.001). Our risk stratification model predicted a 2.7 (95% CI: 2.2 to 3.4) increased risk of AP for a score of &gt;10, with an AUC of 0.85 (95% CI: 0.84 to 0.88).</p> Conclusion <p>AP in HSCT prognosticates adverse outcomes with increased in-hospital mortality, prolonged length of stay, and higher hospitalization costs. Clinicians need to be vigilant in preventing and aggressively managing AP in HSCT.</p> Category of study <p>Population study</p> Impact <p><UnorderedList Mark="Bullet"> <ItemContent> <p>Acute pancreatitis (AP) in pediatric hemopoietic stem cell transplant (HSCT) recipients prognosticates adverse outcomes with increased mortality, prolonged length of stay, and higher hospitalization costs.</p> </ItemContent> <ItemContent> <p>The risk stratification model predicted a 2.7 (95% CI: 2.2 to 3.4) times&#xa0;increased risk of AP for a score of &gt;10, with an AUC of 0.85 (95% CI: 0.84 to 0.88).</p> </ItemContent> <ItemContent> <p>Multivariable analysis showed AP was associated with 1.5 (CI:1.2 to 2, p = 0.001) times increased risk of mortality in pediatric population.</p> </ItemContent> </UnorderedList></p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Acute pancreatitis adversely impacts the outcome in hospitalized pediatric hematopoietic stem cell transplantation recipients

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年1月16日

查看全文
  • Aravind Thavamani,
  • Isabella Zaniletti,
  • Matt Hall,
  • Thomas J. Sferra,
  • Jignesh Dalal,
  • Senthilkumar Sankararaman

摘要

Background

Acute pancreatitis (AP) is one of the serious complications among patients with hematopoietic stem cell transplantation (HSCT). We aimed to evaluate the impact of AP on hospitalization outcomes in pediatric HSCT recipients.

Methods

We retrospectively queried the PHIS database to include all pediatric patients who underwent HSCT between 2005-2024. The study population was divided into those with and without AP, and compared for various demographic and clinical variables. The primary outcome was in-hospital mortality, and secondary outcomes included healthcare resource utilization.

Results

A total of 33,439 HSCT recipients were identified, and the prevalence rate of AP was 1.1%. The AP group had a significantly higher in-hospital mortality rate (22.7% vs. 4.6%), higher median hospitalization costs (USD 698,372 vs. 187,583), and higher median length of stay (138.5 vs. 60 days) (all p < 0.001). Our risk stratification model predicted a 2.7 (95% CI: 2.2 to 3.4) increased risk of AP for a score of >10, with an AUC of 0.85 (95% CI: 0.84 to 0.88).

Conclusion

AP in HSCT prognosticates adverse outcomes with increased in-hospital mortality, prolonged length of stay, and higher hospitalization costs. Clinicians need to be vigilant in preventing and aggressively managing AP in HSCT.

Category of study

Population study

Impact

Acute pancreatitis (AP) in pediatric hemopoietic stem cell transplant (HSCT) recipients prognosticates adverse outcomes with increased mortality, prolonged length of stay, and higher hospitalization costs.

The risk stratification model predicted a 2.7 (95% CI: 2.2 to 3.4) times increased risk of AP for a score of >10, with an AUC of 0.85 (95% CI: 0.84 to 0.88).

Multivariable analysis showed AP was associated with 1.5 (CI:1.2 to 2, p = 0.001) times increased risk of mortality in pediatric population.